| Application no. and date | 01927318.4 (espacenet) (Federated) (European Patent Register), 20010424 | | Patent/reg. no. and date | DK/EP 1280486, 20101117 | | Publication date | 20030205 | | Priority no. and date | US 559711, 20000426 | | EP pub. no. and date |
EP 1280486 20030205 | | Effective date | | | Applicant/owner | Watson Pharmaceuticals, Inc., 311 Bonnie Circle
Corona, CA 92880, US | | Applicant ref. no. | 154563 | | Inventor | EBERT, Charles, D., 1515 South Canterbury Drive
Salt Lake City, UT 84108, US,
SANDERS, Steven, W., 8461 Kings Hill Drive
Salt Lake City, UT 84121, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/216 (2006.01) , A61K 47/10 (2006.01) , A61K 47/14 (2006.01) , A61K 9/70 (2006.01) | | Title | Minimering af bivirkning forbundet med oxybutinin-terapi | | Int. application no. | US2001013135 | | Int. publication no. | WO2001080796 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
